KDR and central nervous system cancer: These studies provide evidence supporting the notion that glioma cells can directly be affected by anti-VEGF or anti-VEGFR treatment and disruption of VEGF-VEGFR autocrine loop in tumor cells maybe result in glioma cell phenotypic change.